Bayer gets FDA priority review for blood cancer drug

German drugmaker Bayer won the U.S. Food and Drug Administration’s priority review status for an experimental drug for a difficult to treat type of blood cancer, bolstering its development pipeline.

Based on results of a Phase II study, the FDA plans to review Bayer’s copanlisib within six months instead of the usual 10 for use against follicular lymphoma which has returned or persisted despite at least two prior therapies, the company said in a statement on Wednesday.

Bayer, which is taking over U.S. seeds group Monsanto, is trying to follow up in its drug development efforts on the recent success of blood thinner Xarelto and anti-blindness treatment Eylea.

“Copanlisib may have a greater success and potential than we initially anticipated,” Bryan Garnier analysts said, adding they would revise their current peak sales estimate of 600 million euros ($666 million).

Bayer has said it was targeting peak annual sales of more than 500 million euros for the compound.

The Phase II trials has previously shown that copanlisib lead to the cancer receding in close to 60 percent of participants.

($1 = 0.9014 euros)

(Reporting by Ludwig Burger, editing by Louise Heavens)

Read More at Reuters

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

The Salad Trend You Didn’t Know You Needed
Woman Goes from Being Morbidly Obese to Dropping 130 Lbs. and Becoming a Personal Trainer
Mom of 3 Drops 120 Lbs. After Having Her Youngest Child: ‘I Wanted to Get Healthy for My Kids’
Woman Who Lost 185 Lbs. Shows Off Excess Skin: ‘I Wanted People to Realize What Obesity Does’
4 Ideas for Using Herbs You Probably Haven’t Thought Of
Lena Dunham’s Trainer Tracy Anderson Says She Wanted to ‘Feel Better’ and Not Make Her Body ‘Look Different’
Ashley Graham on How Parents Can Teach Their Children Body Positivity by Loving Themselves
Is Collagen Really an Anti-Aging Cure-All?
4 Ideas for Using Herbs You Probably Haven’t Thought Of
The Salad Trend You Didn’t Know You Needed
How To Give Vegan ‘Ice Cream’ That Creamy Taste, Minus The Milk
We ❤ Vegetables—and We Want You To Love Them As Much As We Do!
Spread of combat, cholera wreaks misery, collapse in Yemen
India’s drugmakers need more time to meet international standards: industry group
FDA places clinical hold on Concert Pharma’s hair loss drug
Most U.S. troops kicked out for misconduct had mental illness: study